文献速递炎症性肠病消化道肿瘤与早癌

丹麦和芬兰23年间儿童期起病炎症性肠病的癌症发病率和死亡率:一项基于人群的研究

The incidence of cancer and mortality in paediatric onset inflammatory bowel disease in Denmark and Finland during a 23-year period: a population-based study.
PubMed 文献 · Aliment Pharmacol Ther · 2019-05-08

该研究基于丹麦和芬兰国家登记数据,纳入1992至2014年间18岁前确诊的克罗恩病、溃疡性结肠炎或未分类炎症性肠病的患者,随访至2014年底。癌症总体标准化发病比为2.6(95%CI:1.8-3.7),克罗恩病和溃疡性结肠炎分别为2.5(95%CI:1.8-3.4);标准化死亡比在克罗恩病为2.2(95%CI:1.4-3.4)、溃疡性结肠炎为3.7(95%CI:2.7-5.0)。作者认为应重视青少年儿童期起病炎症性肠病患者的癌症监测和心理健康评估。

要点

  • 儿童期起病炎症性肠病患者癌症总体标准化发病比为2.6(95%CI:1.8-3.7)。
  • 克罗恩病和溃疡性结肠炎的标准化死亡比分别为2.2和3.7(95%CI分别为1.4-3.4和2.7-5.0)。
  • 主要死亡原因为癌症、自杀和感染。

核心结论

  • 儿童期起病炎症性肠病患者癌症和死亡风险增加,作者认为这凸显了在青少年儿童期起病炎症性肠病标准诊疗中开展癌症监测和心理健康评估的重要性。

研究设计与样本

  • 基于丹麦和芬兰国家患者登记库的基于人群的队列研究,纳入1992至2014年间18岁前确诊克罗恩病、溃疡性结肠炎或未分类炎症性肠病的患者,并与国家癌症和死亡登记库交叉链接,随访至2014年底。

主要发现

  • 72例随后发生癌症,65例死亡。
  • 癌症总体标准化发病比为2.6(95%CI:1.8-3.7),克罗恩病为2.5(95%CI:1.8-3.4),溃疡性结肠炎为2.5(95%CI:1.8-3.4)。
  • 标准化死亡比在克罗恩病为2.2(95%CI:1.4-3.4),在溃疡性结肠炎为3.7(95%CI:2.7-5.0)。
  • 主要死亡原因为癌症、自杀和感染。

临床怎么用

  • 作者认为应重视青少年儿童期起病炎症性肠病标准诊疗中的癌症监测和心理健康评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent studies report increased risks of both cancer and mortality in paediatric onset inflammatory bowel disease (pIBD) but the reproducibility of this is unknown. AIM: To estimate the risk of cancer and mortality in the Danish and Finnish pIBD population in a 23-year period compared to the general population. METHODS: The pIBD population was defined as individuals registered in the national patient registries with a diagnosis of Crohn's disease (CD), ulcerative colitis (UC) or IBD-unclassified before their 18th birthday from 1992 to 2014. This cohort was cross referenced with the national cancer and mortality registries identifying all pIBD patients who subsequently developed cancer and/ or died and followed up to the end of 2014. Risk estimates are presented as standardised incidence ratios calculated based on incidence figures from the populations. RESULTS: Six thousand six hundred and eight-nine patients with pIBD were identified (median age at follow-up 22.3 years; median follow-up: 9.6 years [interquartile range: 4.8-16.0]). Seventy-two subsequently developed cancer and 65 died. The standardised incidence ratio of cancer in general was 2.6 (95% CI: 1.8-3.7) and 2.5 (95% CI: 1.8-3.4) in CD and UC, respectively. The standardised mortality ratios were 2.2 (95% CI: 1.4-3.4) and 3.7 (95% CI: 2.7-5.0) in CD and UC, respectively. The leading causes for mortality were cancer, suicide and infections. CONCLUSIONS: We found an increased risk of cancer and mortality in pIBD. This underlines the importance of cancer surveillance programs and assessment of mental health in the standard of care in adolescent pIBD patients.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Malham M, Jakobsen C, Paerregaard A, et al. The incidence of cancer and mortality in paediatric onset inflammatory bowel disease in Denmark and Finland during a 23-year period: a population-based study. Aliment Pharmacol Ther. 2019. PMID: 31069829. doi:10.1111/apt.15258

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。